1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 3:Results of the age-adjusted, brain volume-adjusted, and Bonferroni-corrected comparisons among control volunteers and different multiple sclerosis clinical phenotypes
Average D̅ D̅ Histogram Peak Height D̅ Histogram Peak Position Control volunteers vs. all patients with MS <0.00001 <0.00001 0.003 Control volunteers vs. RRMS 0.93 0.08 0.98 Control volunteers vs. PPMS 0.00001 0.00001 0.14 RRMS vs. SPMS <0.00001 <0.00001 0.0009 PPMS vs. SPMS 0.0002 0.07 0.12
Note.—MS indicates multiple sclerosis; RRMS, relapsing-remitting multiple sclerosis; SPMS, secondary progressive multiple sclerosis; PPMS, primary progressive multiple sclerosis. For further details and statistical analysis, see text.